Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KAT2B | Q92831 | 1/20 | 0.40 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 3/20 | 0.33 |
| ▸ | CA2 | P00918 | 3/20 | 0.33 |
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7221126 | 0.89 | TDP1 (0.37) | KAT2BBAZ2BTDP1PDE4BPTPN1 | |
| SCHEMBL6654536 | 0.79 | TDP1 (0.39) | KAT2BBAZ2BTDP1PDE4BPTPN1 | |
| SCHEMBL6766217 | 0.77 | TDP1 (0.40) | KAT2BBAZ2BTDP1PDE4BPTPN1 | |
| SCHEMBL8402440 | 0.77 | TP53 (0.36) | KAT2BBAZ2BTDP1PDE4BPTPN1 | |
| SCHEMBL8954773 | 0.76 | DHFR (0.35) | KAT2BBAZ2BTDP1ALDH1A1SLC6A3 | |
| SCHEMBL8370615 | 0.76 | DHFR (0.35) | KAT2BBAZ2BTDP1ALDH1A1SLC6A3 | |
| SCHEMBL6770014 | 0.76 | TDP1 (0.41) | KAT2BBAZ2BTDP1PDE4BPTPN1 | |
| SCHEMBL8707829 | 0.73 | PDE4B (0.43) | KAT2BBAZ2BTDP1PDE4BPTPN1 | |
| SCHEMBL9535725 | 0.73 | KDM4E (0.44) | KAT2BBAZ2BTDP1ALDH1A1SLC6A3 | |
| SCHEMBL7515178 | 0.73 | TDP1 (0.37) | KAT2BBAZ2BTDP1PDE4BPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6632817-B2 | Use as pesticides such as 2-fluoromethoxyimino-N-methyl-2-((6-aryl-s-triazin-2-yloxy)-phenyl) -acetamide; use on crops as fungicide; microbiocide on wood; chemical synthesis | BAYER AG (DE) | 2003-10-14 | — | — | US | disclosed |
| US-20020028811-A1 | Use as pesticides such as 2-fluoromethoxyimino-N-methyl-2-((6-aryl-s-triazin-2-yloxy)-phenyl) -acetamide; use on crops as fungicide; microbiocide on wood; chemical synthesis | HEINEMANN ULRICH (DE) | 2002-03-07 | — | — | US | disclosed |
| US-6306855-B1 | PESTICIDES, AND ALSO TO NOVEL INTERMEDIATES AND TO A PLURALITY OF PROCESSES FOR THEIR PREPARATION. | BAYER AKTIENGESELLSCHAFT (DE) | 2001-10-23 | — | — | US | disclosed |
| EP-0986542-A1 | FLUOROMETHOXIMINO COMPOUNDS | Bayer Aktiengesellschaft (DE) | 2000-03-22 | — | — | EP | disclosed |
| WO-1998055461-A1 | FLUOROMETHOXIMINO COMPOUNDS | BAYER AKTIENGESELLSCHAFT (DE) | 1998-12-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020028811-A1 | Use as pesticides such as 2-fluoromethoxyimino-N-methyl-2-((6-aryl-s-triazin-2-yloxy)-phenyl) -acetamide; use on crops as fungicide; microbiocide on wood; chemical synthesis | PFAS, DDT, DNPH1 | KAT2B 2731/4885BAZ2B 1887/4885TDP1 1938/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.